The ReadoutThe second act of Gilead’s top scientist & is BACE doomed? By Damian Garde and Meghana Keshavan May 23, 2018 Reprints Alex Hogan/STAT The Readout for May 23, 2018 About the Authors Reprints Damian Garde National Biotech Reporter Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast. [email protected] @damiangarde Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. [email protected] @megkesh
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Exclusive Brittany Trang STAT Plus: Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies
Special Report Lizzy Lawrence STAT Plus: Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted in chronic pain patients
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
